VBI Vaccines to Present Updates on Multiple Programs at the

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
149
VBI Vaccines to Present Updates on Multiple Programs at the World Vaccine Congress

CAMBRIDGE, MASSACHUSETTS--(Marketwired - April 5, 2017) - VBI Vaccines Inc. (NASDAQ:VBIV)(TSX:VBV) ("VBI") is scheduled to present updates on two of its programs at the World Vaccine Congress on Tuesday, April 11, 2017 at 3:40 PM ET and 4:40 PM ET. The event is being held at the Grand Hyatt in Washington, D.C.

VBI-1901: Harnessing Foreign Viral CMV Antigens to Re-Stimulate Anti-Tumor Immunity

Tuesday, April 11 - 3:40 PM ET

During the Cancer & Immunotherapy Sub-Conference, David E. Anderson, Ph.D., VBI's Chief Scientific Officer, will provide an overview of VBI's use of its eVLP Platform directed against cytomegalovirus ("CMV") to target solid tumors that express CMV antigens. Dr. Anderson will present new preclinical biodistribution and immunogenicity data that supports Phase I/IIa development plans for VBI's therapeutic vaccine candidate to treat glioblastoma multiforme ("GBM") , one of the most common and aggressive forms of brain cancer.

Sci-B-Vac™: Hepatitis B Vaccine Phase III Program Update

Tuesday, April 11 - 4:40 PM ET

Francisco Diaz-Mitoma, M.D., Ph.D., VBI's Chief Medical Officer, will present clinical data on Sci-B-Vac ™ , VBI's third-generation hepatitis B vaccine . This data supports VBI's proposed global Phase III clinical program, for which the company is seeking evaluation and approval from the U.S. Food and Drug Administration ("FDA"), Health Canada and the European Medical Agency ("EMA").

Now in its 17th year, the World Vaccine Congress is a well-established global vaccine event attended by international industry leaders, including leading research institutions, government regulators, and life sciences companies.

Dr. Anderson's and Dr. Diaz-Mitoma's presentations will be available on VBI's website, www.vbivaccines.com , following the event.

Event Details

About VBI Vaccines Inc.

VBI Vaccines Inc. ("VBI") is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious disease and immuno-oncology. VBI's first marketed product is Sci-B-Vac™, a hepatitis B ("HBV") vaccine that mimics all three viral surface antigens of the hepatitis B virus; Sci-B-Vac is approved for use in Israel and 14 other countries. VBI's eVLP Platform technology allows for the development of enveloped ("e") virus-like particle ("VLP") vaccines that closely mimic the target virus to elicit a potent immune response. VBI is advancing a pipeline of eVLP vaccines, with lead programs in cytomegalovirus ("CMV") and glioblastoma multiforme ("GBM"). VBI is also advancing its LPV™ Thermostability Platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. VBI is headquartered in Cambridge, MA with research operations in Ottawa, Canada and research and manufacturing facilities in Rehovot, Israel.

Website Home: http://www.vbivaccines.com/

News and Insights: http://www.vbivaccines.com/wire/

Investors: http://www.vbivaccines.com/investors/

Cautionary Statement on Forward-looking Information

Certain statements in this news release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation (collectively, "forward-looking statements") that may not be based on historical fact, but instead relate to future events, including without limitation statements containing the words "believe", "may", "plan", "scheduled," "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. All statements other than statements of historical fact included in this release are forward-looking statement.

Such forward-looking statements are based on a number of assumptions, including assumptions regarding the successful development and/or commercialization of the company's products, including the receipt of necessary regulatory approvals; general economic conditions; that the parties' respective businesses are able to operate as anticipated without interruptions; competitive conditions; and changes in applicable laws, rules and regulations.

Although management believes that the assumptions made and expectations represented by such statements are reasonable, there can be no assurance that a forward-looking statement contained herein will prove to be accurate. Actual results and developments may differ materially from those expressed or implied by the forward-looking statements contained herein and even if such actual results and developments are realized or substantially realized, there can be no assurance that they will have the expected consequences or effects. Factors which could cause actual results to differ materially from current expectations include: the failure to successfully develop or commercialize the company's products; adverse changes in general economic conditions or applicable laws, rules and regulations; and other factors detailed from time to time in the company's reports filed with the U.S Securities and Exchange Commission and the Canadian Securities Commissions.

Given these risks, uncertainties and factors, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based on the company's current expectations, and the company undertakes no obligation to revise or update such forward-looking statements and information to reflect subsequent events or circumstances, except as required by law.

VBI Contact Perri Maduri Communications Executive Phone: (617) 830-3031 Email: info@vbivaccines.com VBI Investor Contact Nell Beattie Director, Corporate Development and Investor Relations Email: ir@vbivaccines.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 89

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
Fold Health's AI: Revolutionizing Patient Care Dynamics

Updated Category News Views 85

AI's Role in Healthcare: From Insight to Action Healthcare's got a resource issue, plain and simple. It's like trying to fill a bathtub with a hole in it—clinicians are swamped, burnout is high, and patients aren't getting the attention they need. Enter Fold Health's AI operating layer, launched with the ambition to realign the equation. Not Just Another Tech Buzzword...

Continue Reading
Ave7® Pioneers AI-Driven Marketplace Evolution

Updated Category News Views 47

AI Reshapes the Agency Paradigm Nobody saw this coming a decade ago, but here we are—AI's taking the wheel, but with humans still riding shotgun. The agency world, particularly the one dealing with e-commerce giants like Amazon, Walmart, and Target, has flipped on its head. Ave7® steps up as the frontrunner, adapting faster than a broker's reflex after a market bell....

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 134

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 96

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 122

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Cardio Partners Hits a Million Milestone with Red Cross

Updated Category News Views 57

One Million Trained, One Million Prepared Ah, a million sounds like just another number, doesn't it? But when someone's life hangs in the balance, those are a million folks ready to jump in and act. Cardio Partners has hit this mighty milestone in CPR, AED, and First Aid training, gaining a pat on the back from none other than the American Red Cross. It's a testament,...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 115

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 217

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 102

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading

Top 5 Most Recently Viewed Articles

Mining Stocks: Resilience Amid Market Fluctuations and Trends

Updated Category News Views 466

Understanding the Mining Stocks' Performance In recent discussions, subscribers to the Mining Stock Journal have raised an intriguing question: Will a significant decline in the broader market be necessary for mining stocks to continue their upward trajectory? This line of thought seems to resonate with several market analysts, but it warrants a closer look. Mining stocks...

Continue Reading
Goliath Resources Unveils Ambitious 40,000-Meter Drill Campaign

Updated Category News Views 191

Exciting Times for Goliath Resources Goliath Resources is embarking on a groundbreaking journey with its largest drill campaign yet, focusing entirely on the high-grade gold discovery known as Surebet. This campaign aims to cover an impressive 40,000 meters and will utilize nine drilling rigs. The motivation for such an extensive drilling program stems from the...

Continue Reading
Who Will Dominate the Semiconductor Sector in 2024?

Updated Category News Views 137

The Competitive Landscape of Semiconductors The semiconductor industry is currently experiencing fierce competition, with three key players at the forefront: Broadcom Inc (NASDAQ: AVGO), Micron Technology Inc (NASDAQ: MU), and Marvell Technology Inc (NASDAQ: MRVL). By examining the specific strengths and hurdles each company faces, investors can gain valuable insights...

Continue Reading
Goldman Sachs' Recent Options Activity Shows Enthusiasm

Updated Category News Views 228

The Bullish Sentiment Surrounding Goldman Sachs In recent times, major financial players have shown a notable bullish sentiment towards Goldman Sachs Gr (NASDAQ: GS). Our analysis of the options market reveals intriguing insights through 37 distinctive trades surrounding this financial powerhouse. When we look deeper into the trading data, it's noteworthy that...

Continue Reading
Eramet's Strategies for Enhanced Operational Efficiency in 2025

Updated Category News Views 305

Analyzing Eramet's Strategic Direction in 2025 Eramet's commitment to operational efficiency has never been more critical than in 2025, especially after encountering significant pressures during the first half of the year. The company's recent announcements underscore an enhancement in various operational protocols, demonstrating a resilient approach towards addressing...

Continue Reading